PT994875E - Derivados de 3-piridil-1-aza-biciclo-alcano para a prevencao e tratamento de desordens do snc - Google Patents
Derivados de 3-piridil-1-aza-biciclo-alcano para a prevencao e tratamento de desordens do sncInfo
- Publication number
- PT994875E PT994875E PT98918598T PT98918598T PT994875E PT 994875 E PT994875 E PT 994875E PT 98918598 T PT98918598 T PT 98918598T PT 98918598 T PT98918598 T PT 98918598T PT 994875 E PT994875 E PT 994875E
- Authority
- PT
- Portugal
- Prior art keywords
- aza
- pyridyl
- bicyclo
- alcano
- bicycle
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
- FDAOGGNPGDPKBY-UHFFFAOYSA-N 2-pyridin-3-yl-1-azabicyclo[2.2.1]heptane Chemical class C1CN2CC1CC2C1=CC=CN=C1 FDAOGGNPGDPKBY-UHFFFAOYSA-N 0.000 abstract 1
- WIEWCOLOPGXZDJ-UHFFFAOYSA-N 2-pyridin-3-yl-1-azabicyclo[3.2.2]nonane Chemical compound C1CN2CCC1CCC2C1=CC=CN=C1 WIEWCOLOPGXZDJ-UHFFFAOYSA-N 0.000 abstract 1
- SXRRAFMKMZGQJY-UHFFFAOYSA-N 3-pyridin-3-yl-1-azabicyclo[3.2.2]nonane Chemical compound C1CN(C2)CCC1CC2C1=CC=CN=C1 SXRRAFMKMZGQJY-UHFFFAOYSA-N 0.000 abstract 1
- PHXZTDLBLWHZEJ-UHFFFAOYSA-N 7-pyridin-3-yl-1-azabicyclo[2.2.1]heptane Chemical compound C1CN2CCC1C2C1=CC=CN=C1 PHXZTDLBLWHZEJ-UHFFFAOYSA-N 0.000 abstract 1
- BXZMIGKZXVFLGL-UHFFFAOYSA-N 7-pyridin-3-yl-1-azabicyclo[3.2.2]nonane Chemical compound C1CN2CCCC1CC2C1=CC=CN=C1 BXZMIGKZXVFLGL-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000027089 Parkinsonian disease Diseases 0.000 abstract 1
- 206010034010 Parkinsonism Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 230000002950 deficient Effects 0.000 abstract 1
- 229960003638 dopamine Drugs 0.000 abstract 1
- 230000003957 neurotransmitter release Effects 0.000 abstract 1
- YJYPZLAZNIGNRP-UHFFFAOYSA-N rjr-2429 Chemical compound C1CN2CCC1CC2C1=CC=CN=C1 YJYPZLAZNIGNRP-UHFFFAOYSA-N 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/885,768 US6624173B1 (en) | 1997-06-30 | 1997-06-30 | Pharmaceutical compositions for treating and/or preventing CNS disorders |
| US08/885,397 US6525065B1 (en) | 1997-06-30 | 1997-06-30 | Pharmaceutical compositions and methods for effecting dopamine release |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT994875E true PT994875E (pt) | 2004-06-30 |
Family
ID=27128761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98918598T PT994875E (pt) | 1997-06-30 | 1998-04-22 | Derivados de 3-piridil-1-aza-biciclo-alcano para a prevencao e tratamento de desordens do snc |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0994875B1 (pt) |
| JP (1) | JP2002511090A (pt) |
| AT (1) | ATE261443T1 (pt) |
| AU (1) | AU7149798A (pt) |
| CA (1) | CA2294990C (pt) |
| DE (1) | DE69822300T2 (pt) |
| DK (1) | DK0994875T3 (pt) |
| ES (1) | ES2214707T3 (pt) |
| PT (1) | PT994875E (pt) |
| WO (1) | WO1999000385A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6953855B2 (en) | 1998-12-11 | 2005-10-11 | Targacept, Inc. | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| US6432975B1 (en) | 1998-12-11 | 2002-08-13 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| FR2791678B1 (fr) * | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique |
| WO2001032264A1 (en) * | 1999-11-01 | 2001-05-10 | Targacept, Inc. | Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| US6890935B2 (en) | 1999-11-01 | 2005-05-10 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
| US20050131051A1 (en) * | 2000-08-21 | 2005-06-16 | Shaomeng Wang | 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
| WO2002024681A2 (en) | 2000-09-20 | 2002-03-28 | Ortho-Mcneil Pharmaceutical, Inc. | Pyrazine derivatives as modulators of tyrosine kinases |
| GB0202873D0 (en) * | 2002-02-07 | 2002-03-27 | Novartis Ag | Organic compounds |
| JP4923630B2 (ja) * | 2006-03-02 | 2012-04-25 | 宇部興産株式会社 | ４−置換テトラヒドロピランの製造方法 |
| TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
| JP5413441B2 (ja) * | 2011-12-09 | 2014-02-12 | 宇部興産株式会社 | ４−置換テトラヒドロピランの製造方法 |
| CN104311514B (zh) * | 2014-10-14 | 2016-06-22 | 安徽扬子化工有限公司 | 3-羟甲基四氢呋喃酯的合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0412798A3 (en) * | 1989-08-08 | 1992-07-01 | Merck Sharp & Dohme Ltd. | Substituted pyridines, their preparation, formulations and use in dementia |
| US5242935A (en) * | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| WO1995003306A1 (en) * | 1993-07-22 | 1995-02-02 | E.I. Du Pont De Nemours And Company | Arthropodicidal azacyclic heterocycles |
| US5510355A (en) * | 1994-09-06 | 1996-04-23 | Bencherif; Merouane | Depolarizing skeletal muscle relaxants |
| WO1996036637A1 (en) * | 1995-05-17 | 1996-11-21 | R.J. Reynolds Tobacco Company | Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
-
1998
- 1998-04-22 DE DE69822300T patent/DE69822300T2/de not_active Expired - Fee Related
- 1998-04-22 JP JP50551699A patent/JP2002511090A/ja not_active Ceased
- 1998-04-22 CA CA002294990A patent/CA2294990C/en not_active Expired - Fee Related
- 1998-04-22 WO PCT/US1998/008145 patent/WO1999000385A1/en not_active Ceased
- 1998-04-22 AU AU71497/98A patent/AU7149798A/en not_active Abandoned
- 1998-04-22 PT PT98918598T patent/PT994875E/pt unknown
- 1998-04-22 DK DK98918598T patent/DK0994875T3/da active
- 1998-04-22 ES ES98918598T patent/ES2214707T3/es not_active Expired - Lifetime
- 1998-04-22 AT AT98918598T patent/ATE261443T1/de not_active IP Right Cessation
- 1998-04-22 EP EP98918598A patent/EP0994875B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2214707T3 (es) | 2004-09-16 |
| WO1999000385A1 (en) | 1999-01-07 |
| CA2294990A1 (en) | 1999-01-07 |
| EP0994875A1 (en) | 2000-04-26 |
| ATE261443T1 (de) | 2004-03-15 |
| AU7149798A (en) | 1999-01-19 |
| JP2002511090A (ja) | 2002-04-09 |
| DE69822300D1 (de) | 2004-04-15 |
| DE69822300T2 (de) | 2005-03-10 |
| CA2294990C (en) | 2007-03-06 |
| DK0994875T3 (da) | 2004-06-21 |
| EP0994875B1 (en) | 2004-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004108668A3 (en) | Alpha-7 neuronal nicotinic receptor ligands: compositions and methods of use | |
| SI1678172T1 (sl) | AzabicikliŽŤne spojine za lajšanje boleŽŤine in zdravljenje motenj centralnega ĹľivŽŤnega sistema | |
| Maelicke et al. | Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease | |
| PT994875E (pt) | Derivados de 3-piridil-1-aza-biciclo-alcano para a prevencao e tratamento de desordens do snc | |
| EP1219622A3 (en) | Pharmaceutical compositions for CNS and other disorders | |
| MXPA02001306A (es) | Composiciones farmaceuticas para el tratamiento de enfermedades del sistema nervioso central y otras enfermedades. | |
| CY1983A (en) | Central Cholecystokinin antagonists for treatment of psychiatric disorders | |
| MY130145A (en) | Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders. | |
| PH31335A (en) | Naphthalamides as central nervous system agent. | |
| PL398445A1 (pl) | Kompozycje farmaceutyczne zawierające dekstrometorfan i chininę do leczenia zaburzeń neurologicznych | |
| NO20041166L (no) | Anvendelse av optisk rent (+) norcisaprid sammen med et annet terapeutisk middel for fremstilling av et medikament | |
| DE68912419D1 (de) | Verwendung von Uridin zur Behandlung nervöser Störungen. | |
| IL113436A0 (en) | Neurotransmitter release enhancers | |
| AU4038000A (en) | 4-substituted quinoline derivatives as gaba receptor ligands | |
| DE69224448D1 (de) | Imidazol-Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung | |
| GR3019782T3 (en) | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents | |
| DE69330754D1 (de) | 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINE ALS NMDA REZEPTOR ANTAGONISTEN | |
| Beale et al. | ECT for OCD. | |
| HU9502848D0 (en) | Imidazoloquinoxalinone derivatives as eaa antagonists | |
| NZ515613A (en) | Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands | |
| AU2002243310A1 (en) | Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders |